(Q33382185)

26 July 2017

title

A phase II combination trial with recombinant human tumor necrosis factor and gamma interferon in patients with colorectal cancer (English)

1 reference

26 July 2017

main subject

phase II clinical trial

0 references

1 reference

1 reference

W Fiedler

1

1 reference

26 July 2017

W Zeller

2

1 reference

26 July 2017

C J Peimann

3

1 reference

26 July 2017

H J Weh

4

1 reference

26 July 2017

D K Hossfeld

5

1 reference

26 July 2017

language of work or name

1 reference

1 April 1991

1 reference

26 July 2017

published in

Klinische Wochenschrift

1 reference

26 July 2017

volume

69

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

261-268

1 reference

Tumor necrosis factor induces hemorrhagic necrosis of a sarcoma

26 July 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF01666852

Gamma interferon enhances macrophage transcription of the tumor necrosis factor/cachectin, interleukin 1, and urokinase genes, which are controlled by short-lived repressors

21 January 2018

1 reference

12 December 2020

Effect of tumor necrosis factor alpha on mitogen-activated human B cells

1 reference

12 December 2020

Regulation of macrophage tumor necrosis factor production by prostaglandin E2.

1 reference

12 December 2020

Potentiation of lymphokine-induced macrophage activation by tumor necrosis factor-alpha

1 reference

12 December 2020

The antitumor function of tumor necrosis factor (TNF) II. Analysis of the role of endogenous TNF in endotoxin-induced hemorrhagic necrosis and regression of an established sarcoma

1 reference

12 December 2020

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor

1 reference

12 December 2020

Cooperative effect of interferon-gamma and tumor necrosis factor-alpha on the induction of the class II antigen-associated invariant chain expression

1 reference

12 December 2020

Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity

1 reference

12 December 2020

The toxic effects of tumor necrosis factor in vivo and their prevention by cyclooxygenase inhibitors

1 reference

12 December 2020

Tumor necrosis factor (TNF).

1 reference

12 December 2020

Tumor necrosis factor inhibiting angiogenesis in vitro

1 reference

12 December 2020

The antitumor function of tumor necrosis factor (TNF), I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity

1 reference

12 December 2020

Characterization of the antitumor activities of human tumor necrosis factor-alpha and the comparison with other cytokines: induction of tumor-specific immunity

1 reference

12 December 2020

Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer

1 reference

12 December 2020

Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

1 reference

12 December 2020

Antitumor activity of murine tumor necrosis factor (TNF) against transplanted murine tumors and heterotransplanted human tumors in nude mice

1 reference

12 December 2020

Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon

1 reference

12 December 2020

Human tumor xenografts treated with recombinant human tumor necrosis factor alone or in combination with interferons

1 reference

12 December 2020

Persistence of the hypertriglyceridemic effect of tumor necrosis factor despite development of tachyphylaxis to its anorectic/cachectic effects in rats.

1 reference

12 December 2020

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

12 December 2020

A human inhibitor of tumor necrosis factor alpha

1 reference

12 December 2020

Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.

1 reference

12 December 2020

Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells.

1 reference

12 December 2020

Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors

1 reference

12 December 2020

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

12 December 2020

Tumour necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, γ-interferon and interleukin-1

1 reference

12 December 2020

Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas

1 reference

12 December 2020

Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice

1 reference

12 December 2020

A phase I trial of recombinant human tumor necrosis factor and interferon-gamma: effects of combination cytokine administration in vivo

1 reference

12 December 2020

Immunoregulatory activity of recombinant human tumor necrosis factor (TNF)-alpha: induction of TNF receptors on human T cells and TNF-alpha-mediated enhancement of T cell responses

1 reference

12 December 2020

Cures and partial regression of murine and human tumors by recombinant human tumor necrosis factor

1 reference

12 December 2020

Phase I trial of recombinant human gamma-interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer

1 reference

12 December 2020

Tumor necrosis factor-alpha and tumor necrosis factor-beta (lymphotoxin) stimulate the production of granulocyte-macrophage colony-stimulating factor, macrophage colony-stimulating factor, and IL-1 in vivo

1 reference

12 December 2020

Alpha-globulins suppress human leukocyte tumor necrosis factor secretion.

1 reference

12 December 2020

Inhibition of cytokine production by cyclosporin A and transforming growth factor beta

1 reference

12 December 2020

Shock and tissue injury induced by recombinant human cachectin

1 reference

12 December 2020

Regulation of tumor necrosis factor gene expression in colorectal adenocarcinoma: in vivo analysis by in situ hybridization

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01666852

1 reference

26 July 2017

1 reference